IECM
ANGO icon

Intrinsic Edge Capital Management’s AngioDynamics ANGO Stock Holding History

Intrinsic Edge Capital Management’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-100,000
Closed -$1.21M – 215
2020
Q3 		$1.21M Buy
+100,000
New +$949K 0.08% 214

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Intrinsic Edge Capital Management's ANGO Position: Q4 2020 in Review

Intrinsic Edge Capital Management sold out of AngioDynamics (ANGO) in Q4 2020, closing a stake of 100,000 shares — an estimated $1.21M sold.

Intrinsic Edge Capital Management first reported a position in ANGO in Q3 2020 and held it in 1 quarter. The position peaked at $1.21M in Q3 2020. 147 funds tracked by Wall St. Rank hold ANGO as of Q4 2020.

  • Intrinsic Edge Capital Management reported no remaining AngioDynamics position as of Q4 2020 after selling out during the quarter.
  • Intrinsic Edge Capital Management sold 100,000 AngioDynamics shares in Q4 2020, an estimated $1.21M.
  • Intrinsic Edge Capital Management first reported a position in AngioDynamics in Q3 2020 and held it in 1 quarter.
  • Intrinsic Edge Capital Management's AngioDynamics position peaked at $1.21M in Q3 2020.
  • 147 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2020.

Based on Intrinsic Edge Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.